Cargando…

Estimating the Time to Diagnosis and the Chance of Spontaneous Clearance During Acute Hepatitis C in Human Immunodeficiency Virus-Infected Individuals

BACKGROUND: Hepatitis C virus (HCV) infection is often asymptomatic, and the date of infection is almost impossible to determine. Furthermore, spontaneous clearance (SC) may occur, but little is known about its time of occurrence. METHODS: Data on human immunodeficiency virus (HIV)-HCV coinfected in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ragonnet, Romain, Deuffic-Burban, Sylvie, Boesecke, Christoph, Guiguet, Marguerite, Lacombe, Karine, Guedj, Jeremie, Rockstroh, Jürgen K., Yazdanpanah, Yazdan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414115/ https://www.ncbi.nlm.nih.gov/pubmed/28480234 http://dx.doi.org/10.1093/ofid/ofw235

Ejemplares similares

Assessing complex interventions: a systematic review of outcomes used in randomised controlled trials on STI partner notification in high-income countries
por: Sawras, Victoire, et al.
Publicado: (2023)

Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study
por: Champenois, Karen, et al.
Publicado: (2013)

Hepatitis C virus (HCV) incidence among men who have sex with men (MSM) living with HIV: results from the French Hospital Database on HIV (ANRS CO4-FHDH) cohort study, 2014 to 2017
por: Castry, Mathieu, et al.
Publicado: (2021)

Cost‐effectiveness of hepatitis C virus test‐and‐treat and risk reduction strategies among men who have sex with men living with HIV in France
por: Castry, Mathieu, et al.
Publicado: (2022)

Quality of life in patients with chronic hepatitis C infection: Severe comorbidities and disease perception matter more than liver-disease stage
por: Cossais, Sabrina, et al.
Publicado: (2019)

HepCare Europe: a new user-friendly hepatitis C care service model. What have we learned? What are the remaining challenges?
por: Rockstroh, Jürgen Kurt, et al.
Publicado: (2019)

Targeted vs. systematic early antiviral treatment against A(H1N1)v influenza with neuraminidase inhibitors in patients with influenza-like symptoms: Clinical and economic impact
por: Deuffic-Burban, Sylvie, et al.
Publicado: (2009)

Impact of Drug Stock-Outs on Death and Retention to Care among HIV-Infected Patients on Combination Antiretroviral Therapy in Abidjan, Côte d'Ivoire
por: Pasquet, Armelle, et al.
Publicado: (2010)

Influence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients: Pooled Analyses of the STARTMRK and QDMRK Studies
por: Squires, Kathleen, et al.
Publicado: (2017)

Spontaneous Clearance of Vertically Acquired Hepatitis C Infection: Implications for Testing and Treatment
por: Ades, A E, et al.
Publicado: (2022)

Costs and cost-effectiveness of different follow-up schedules for detection of occupational hepatitis C virus infection
por: Deuffic-Burban, S, et al.
Publicado: (2008)

The Effect of Hepatitis C Virologic Clearance on Cardiovascular Disease Biomarkers in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
por: Chew, Kara W., et al.
Publicado: (2014)

Simultaneous Human Immunodeficiency Virus-Hepatitis B-Hepatitis C Point-of-Care Tests Improve Outcomes in Linkage-to-Care: Results of a Randomized Control Trial in Persons Without Healthcare Coverage
por: Bottero, Julie, et al.
Publicado: (2015)

Is expert opinion reliable when estimating transition probabilities? The case of HCV-related cirrhosis in Egypt
por: Cousien, Anthony, et al.
Publicado: (2014)

A chance for reform: The environmental impact of travel for general surgery residency interviews
por: Fung, Benjamin SC, et al.
Publicado: (2021)

Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study
por: Smith, Graham H R, et al.
Publicado: (2021)

Association of Hepatitis B Core-Related Antigen and Antihepatitis B Core Antibody With Liver Fibrosis Evolution in Human Immunodeficiency Virus-Hepatitis B Virus Coinfected Patients During Treatment With Tenofovir
por: Cruchet, Romuald, et al.
Publicado: (2020)

Twenty-Year Evolution of Hepatitis B Virus and Human Immunodeficiency Virus Prevalence and Incidence in Voluntary Blood Donors in Côte d’Ivoire
por: Seri, Benjamin, et al.
Publicado: (2018)

Parasite Clearance and Artemether Pharmacokinetics Parameters Over the Course of Artemether-Lumefantrine Treatment for Malaria in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Ugandan Children
por: Kajubi, Richard, et al.
Publicado: (2016)

Occult Hepatitis B Virus Infection: An Old Entity With Novel Clinical Involvements
por: Malagnino, Vincenzo, et al.
Publicado: (2018)

Human Immunodeficiency Virus (HIV) Genetic Diversity Informs Stage of HIV-1 Infection Among Patients Receiving Antiretroviral Therapy in Botswana
por: Ragonnet-Cronin, Manon, et al.
Publicado: (2021)

Hepatitis C Virus (HCV) Clearance After Treatment With Direct-Acting Antivirals in Human Immunodeficiency Virus (HIV)-HCV Coinfection Modulates Systemic Immune Activation and HIV Transcription on Antiretroviral Therapy
por: Ghiglione, Yanina, et al.
Publicado: (2020)

Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus
por: Sax, Paul E, et al.
Publicado: (2020)

Learning by chance: Investigating gaps in transgender care education amongst family medicine, endocrinology, psychiatry and urology residents
por: Fung, Raymond, et al.
Publicado: (2020)

Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients
por: Anadol, Evrim, et al.
Publicado: (2018)

Intervention Packages to Reduce the Impact of HIV and HCV Infections Among People Who Inject Drugs in Eastern Europe and Central Asia: A Modeling and Cost-effectiveness Study
por: Mabileau, Guillaume, et al.
Publicado: (2018)

Routine HIV Screening in France: Clinical Impact and Cost-Effectiveness
por: Yazdanpanah, Yazdan, et al.
Publicado: (2010)

Viral Burden and Clearance in Asymptomatic COVID-19 Patients
por: Gunatilaka, Avanka B, et al.
Publicado: (2022)

Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2
por: Rockstroh, Jürgen K, et al.
Publicado: (2017)

Failure of Early Mycological Clearance in HIV-Negative Cryptococcal Meningitis
por: Su, Zhihui, et al.
Publicado: (2023)

Characterization of Rare Spontaneous Human Immunodeficiency Virus Viral Controllers Attending a National United Kingdom Clinical Service Using a Combination of Serology and Molecular Diagnostic Assays
por: Khan, Maryam, et al.
Publicado: (2023)

Influence of Hepatitis C Coinfection and Treatment on Risk of Diabetes Mellitus in HIV-Positive Persons
por: Mocroft, Amanda, et al.
Publicado: (2020)

Histoplasmosis in Patients With Cell-Mediated Immunodeficiency: Human Immunodeficiency Virus Infection, Organ Transplantation, and Tumor Necrosis Factor-α Inhibition
por: Luckett, Keith, et al.
Publicado: (2014)

Interplay Between Geography and HIV Transmission Clusters in Los Angeles County
por: Skaathun, Britt, et al.
Publicado: (2021)

Lung Function in Women With and Without Human Immunodeficiency Virus
por: Wang, Richard J, et al.
Publicado: (2022)

Overall Vertical Transmission of Hepatitis C Virus, Transmission Net of Clearance, and Timing of Transmission
por: Ades, Anthony E, et al.
Publicado: (2022)

Advanced Human Immunodeficiency Virus Disease at Diagnosis in Mozambique and Swaziland
por: Kujawski, Stephanie A, et al.
Publicado: (2017)

Low Rates of Contraception Use in Women With Human Immunodeficiency Virus
por: Bhatta, Manasa, et al.
Publicado: (2022)

1965. Safety and Efficacy of Glecaprevir/Pibrentasvir in Patients With Chronic Hepatitis C Virus Genotypes 1–6 and Human Immunodeficiency Virus-1 Co-Infection: An Integrated Analysis of Two Phase 3 Clinical Trials
por: Rockstroh, Jurgen K, et al.
Publicado: (2018)

Differential Effects of Antimalarial Drugs on Parasite Clearance Rates Are Reflected by Plasmodium falciparum Ring Ratio
por: Saidi, Alexuse M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c4kfitp9r9m8toa1steo3s3gj9